Halitosis Treatment Market: Segmental Analysis
The global halitosis treatment market has been segmented on the basis of indication, type, drug treatment, and diagnostic test.
By mode of type, the global halitosis treatment market has been segmented into pathological halitosis and others.
By mode of indication, the global halitosis treatment market has been segmented into liver, respiratory, gastrointestinal, kidney, systemic, and others.
By mode of diagnostic test, the global Chronic Halitosis Treatment market has been segmented into gas chromatography, halimeter, β-galactosidase activity assay, BANA test, and other tests.
By mode of drug treatment, the global halitosis treatment market has been segmented into antiseptic, antacids, ranitidine and other drugs.
Halitosis Treatment Market - Market Scenario
The global halitosis treatment market is predicted to register 18.58% CAGR during the forecast period (2022-2027). The market is anticipated to garner USD 22,153.4 billion owing to the increasing incidences of periodontal diseases, asserts Market Research Future (MRFR). Halitosis is referred to as a clinical condition which is characterized by an unpleasant odor of the mouth owing to several chronic and periodontal diseases. Halitosis has become one of the major social problems which have affected a large number of the population globally.
Halitosis Treatment Market - Competitive Dashboard
The noteworthy players operating the global halitosis treatment market are Listerine (U.S), Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz LLC (U.S), Rowpar Pharmaceuticals Inc. (U.S), Abbott (U.S), and AstraZeneca (U.S).
Drivers and Constraints Impacting the Market
Halitosis is mainly caused due to lack of awareness regarding the diagnosis of the particular disease and also lack of oral hygiene. The global halitosis treatment market is forecasted to demonstrate a stellar growth rate owing to the accelerating geriatric population, availability of a varied range of dental care products in the market and increasing incidences of periodontal diseases across the world. The market is getting enough tailwinds from quarters such as advancements in healthcare technologies. Also, initiatives by the government along with technological support are some of the other major factors highly contributing to the market growth. Moreover, surgical, endodontic, and pathological factors like a non-vital tooth with fistula which drains into the mouth and exposed tooth pulps, oral cavity pathologies, oral cancer, healing wounds, extractions or prosthetics, and ulcerations are some of the prominent factors influencing the market growth to a great extent. Such factors lead to plaque or food retention area, increasing amount of bacteria, the decay of amino acids, the decrease in saliva flow, and tissue breakdown. Additionally, manufacturers are focused on the approval and development of new products besides collaborations with other industry players, thereby propelling the market growth.
On the flip side, lack of awareness among the global population regarding the diagnosis and treatment of halitosis is predicted to slow down the market growth to a large extent.
September 11, 2022: The Arizona Bioindustry Association has honored the AZBio Fast Lane Award to Rowpar Pharmaceuticals, Inc., at the 2022 AZBio Awards for developing products for people to maintain oral hygiene. The organization is dedicated to offering CloSYS oral health products, which contains Cloralstan. The ingredient attacks microorganisms and destroys pathogens associated with gum diseases and maintains oral hygiene.
Halitosis Treatment Market - Regional Insights
Geographically, the Halitosis Treatment Market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.
Among all the regions, the American region is considered to occupy a significant share and is estimated to maintain its dominance in the coming years. The growth is credited to the extensive use of oral care products like mouthwashes, toothpaste, mouth sprays, etc. Also, with the increasing prevalence of gum diseases, the market in this region is presumed to flourish.
The European region is anticipated to occupy the second largest position globally owing to the rising awareness associated with halitosis and its available products available for treatment. Additionally, the augmenting demand for oral care products further influences the market growth in this region.
The Asia Pacific is predicted to expand at a rapid pace owing to the augmenting prevalence of chronic diseases like respiratory diseases, diabetes, liver or kidney failure. Furthermore, with the growing geriatric population suffering from such chronic diseases also influences the market growth to a great extent in this region.
Meanwhile, the Middle East & Africa is presumed to experience a moderate growth rate during the assessment period owing to the poor economic conditions coupled with the lack of awareness regarding oral health.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America